Leafio partners with Independent Pharmacies Australia; Dr Jean Claude Scicluna joins Helius Therapeutics
Jan 28, 2025•6 months ago
Contract Type
partnership
Description
Leafio has formed a strategic partnership with Independent Pharmacies Australia (IPA) to provide advanced technologies, expertise, and support to IPA dispensaries. The partnership aims to optimize operations, enhance patient experience, and provide exclusive discounts to IPA pharmacists. Additionally, Dr. Jean Claude Scicluna has joined Helius Therapeutics as the new medical education manager, bringing extensive experience in medicinal cannabis education from around the world.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months